Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.21.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2021
Investments All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents As of March 31, 2021, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

57,435

 

 

$

 

 

$

57,435

 

 

$

57,435

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

70,024

 

 

 

 

 

 

70,024

 

 

 

70,024

 

Total

 

$

127,459

 

 

$

 

 

$

127,459

 

 

$

127,459

 

 

As of December 31, 2020, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

44,795

 

 

$

 

 

$

44,795

 

 

$

44,795

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

70,022

 

 

 

 

 

 

70,022

 

 

 

70,022

 

Total

 

$

114,817

 

 

$

 

 

$

114,817

 

 

$

114,817